What's the Skinny: New Pharmacologic Treatment Options for Obesity Management
Release Date: February 25, 2013 Expiration Date: February 28, 2014
Target Audience This activity has been designed to meet the educational needs of osteopathic primary care physicians and other health care professionals who are involved in managing and treating patients who are obese.
Program Overview The obesity epidemic is one that resonates with people of all ethnicities, races, and religions and both sexes. Not only is obesity present in every country in the world, but it is also consistently featured in the media as a problem that is growing vastly worse over time. To combat this ever-growing problem, physicians will need to make adjustments in the way that they treat overweight patients. For the success of physician-encouraged weight loss, it is essential that healthcare professionals are given continuous opportunities to learn about the different treatment options available to obese patients as well as the tactics that may aid those patients in achieving sustained weight loss. Simply stated, medical options to stimulate initial or sustained weight loss are limited. Few pharmacologic therapies are available to treat obese patients and even fewer healthcare professionals understand the data, thereby making most too uncomfortable to recommend such therapies to their patients. Treating physicians often question the success of pharmacologic agents for obesity in addition to having concerns about which patient populations are even able to begin such a treatment. Continuous education for healthcare professionals highlighting the available and upcoming treatment options for overweight patients as well as the criteria for recommending a pharmacologic agent to patients is critical. One additional hurdle that clinicians face when recommending weight loss therapy to patients is the lack of insurance coverage for weight loss counseling and the subsequent recommended therapy. The recent success of acquiring Medicare reimbursement for weight loss counseling in the obese patient population has been a great victory for patients and healthcare professional alike, bringing the field closer to establishing weight loss counseling as "standard of care" in obese patients. With increasing education targeted toward healthcare professionals instead of marketing products to overweight patients, we will begin to turn the tides of the obesity epidemic and lead to improvements in quality of life for people all over the world.
Accreditation Statement The AOA has designated the American Osteopathic Association of Medical Informatics (AOAMI) as an accredited CME sponsor. This activity was planned and implemented through the collaboration of the AOA and the AOAMI. The AOA Council on Continuing Medical Education has approved this activity for 1 AOA Category 1-B credit.
Your statement of credit will be issued immediately upon successful completion of the quiz, and your AOA CME record will be updated within 24-48 hours.
Faculty Robert Kushner, MD (Chairperson/Moderator) Professor of Medicine Northwestern University Feinberg School of Medicine Chicago, IL Christopher D. Still, DO, FACN, FACP Medical Director, Center for Nutrition and Weight Management Director, Geisinger Obesity Institute Associate, Department of Gastroenterology & Nutrition Geisinger Health System Danville, PA Jeffrey S. Freeman, DO, FACN, FACP Professor Chair and Course Director Endocrinology in the Division of Endocrinology Department of Internal Medicine Philadelphia College of Osteopathic Medicine Philadelphia, PA Faculty Disclosure Statements Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Within the past 12 months, the following individuals in positions to control the content of this program (eg, planners, faculty, content reviewers) reported the following financial relationships or relationships to products or devices they or their spouse/life partner have had with commercial interests related to the content of this CME activity:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Credit Hours: 1.0 Grantor: Vivus This CME activity is jointly developed by the American Osteopathic Association, Postgraduate Institute for Medicine and CME Incite. Method of Participation and Request for Credit There are no fees for participating and receiving AOA Category 1-B credit for this activity. During this period February 25, 2013, through February 28, 2014, participants must read the learning objectives and faculty disclosures and study the educational activity. If you wish to receive acknowledgement for completing this activity, please complete the post-test and evaluation. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Osteopathic Association (AOA), CME Incite, and Vivus do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the AOA, CME Incite, and Vivus. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Software Requirements Adobe Acrobat Reader Internet Explorer 7 or greater Firefox (Latest Version) Safari (Latest Version) Internet Explorer is not supported on the Macintosh. Windows XP or above Mac OS 10.4
Copyright© ® and Centricity™ are all registered trademarks of CECity.com Inc. All rights reserved.